Advanced Biomed Inc.

(a) Capital structure and liquidity: The company reports total assets of $10.65 million and total liabilities of $1.44 million, resulting in total equity of $9.21 million. The debt-to-equity ratio is 0.0, indicating no long-term debt. The current ratio is 7.38, suggesting strong short-term liquidity coverage. However, operating cash flow is negative at -$1.36 million, and free cash flow is -$1.38 million, despite a net income of $5.98 million. This divergence highlights non-cash gains or working capital changes driving profitability rather than operational cash generation.

(b) Profitability and returns: The company reports a return on equity (ROE) of 64.95% and a return on assets (ROA) of 56.19%. These figures are exceptionally high, likely driven by the low equity base and non-recurring gains. The price-to-earnings ratio is 3.64, and the price-to-book ratio is 2.4. Without cohort medians for comparison, these ratios appear attractive in isolation but must be viewed in the context of the negative cash flow and going concern flags.

(c) Segments and geography: No segment or geographic revenue breakdown is provided in the input data. The analysis must rely on the aggregate financials.

(d) Growth trajectory: Historical period data is not provided in the input. The financial snapshot is for Q3 2026. The company went public in March 2025, raising $5.49 million in net proceeds. The lack of historical trend data prevents a detailed growth analysis.

(e) Risk factors: The risk assessment flags high liquidity risk (contradicted by the high current ratio, but likely referring to operational sustainability) and medium dilution risk. Key flags include "going-concern or substantial-doubt language" in filings and mentions of dilution or offering risk. The negative operating cash flow and reliance on financing activities (as seen in the cash flow statement excerpt) support the going concern warning.

(f) Recent events: On March 7, 2025, the company closed its IPO, selling 1.64 million shares at $4.00 per share. A 1-for-20 reverse split occurred on February 20, 2026. On July 20, 2026, the stock experienced an extraordinary up move of 74.73% on volume 413 times the 20-day average, closing at $11.20. This volatility suggests speculative trading rather than fundamental re-rating.